$0.4894
0.02876.23%
Ult. Agg.: Oct 29, 4:26 AM
Caribou Biosciences (CRBU) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.31 | $-0.31 | $-0.32 | $-0.36 |
| Actual | $-0.24 | $-0.26 | $-0.28 | $-0.30 |
| Surprise | +22.6% | +16.1% | +12.5% | +16.7% |
| Revenue | ||||
| Estimate | $2.3M | $2.2M | $2.2M | $2.1M |
| Actual | $1.5M | $2.4M | $3.9M | $2.2M |
| Surprise | -34.7% | +6.77% | +80.3% | +2.60% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.26 | $-0.28 | $-0.11 | $-0.08 |
| Revenue | ||||
| Consensus | $1.6M | $15.0M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.24 | $-0.31 | 22.6 % |
| Q1 | May 7, 2026 | $-0.26 | $-0.31 | 16.1 % |
| Q4 | Mar 5, 2026 | $-0.28 | $-0.32 | 12.5 % |
| Q3 | Nov 12, 2025 | $-0.30 | $-0.36 | 16.7 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $1.50M | $2.30M | -34.7 % |
| Q1 | May 7, 2026 | $2.40M | $2.25M | 6.77 % |
| Q4 | Mar 5, 2026 | $3.94M | $2.19M | 80.3 % |
| Q3 | Nov 12, 2025 | $2.20M | $2.14M | 2.60 % |